Notice of Intent to Sole Source – Stemcell Technologies
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
The purpose of this acquisition is to purchase cell separator kits for the Department of Laboratory Medicine (DLM) at National Institutes of Health (NIH) Clinical Center (CC).
• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-000433
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order STEMCELL TECHNOLOGIES INC, located at 6425 S 216th St Bldg F, Kent, WA, on a firm fixed price sole source award basis to provide EasySep cell separator kits for the Department of Laboratory Medicine (DLM) at National Institutes of Health (NIH) Clinical Center (CC).
StemCell Technologises is the sole manufacturer of these kits used on the RoboSep instruments currently
used in DLM. No other vendors can supply them to meet the clinical and research requirements of the Department of Laboratory Medicine.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by December 19, 2025 at 12pm EST.